Hyperbaric Oxygen Therapy for Multiple Sclerosis: What the Evidence Shows

Sarah had been living with multiple sclerosis for eight years when a friend mentioned hyperbaric oxygen therapy. Her neurologist had adjusted her medications twice already, and the fatigue still hit like a wall every afternoon. She started researching, and what she found was a mix of passionate patient testimonials and cautious medical opinions.

If you are exploring hyperbaric oxygen therapy for multiple sclerosis, you are not alone. Thousands of MS patients worldwide have tried pressurized oxygen treatment, particularly in the UK where dedicated MS therapy centers have offered it since the 1980s. But what does the clinical evidence actually show? And is it worth considering alongside your existing treatment plan?

This guide breaks down the research, explains what symptoms HBOT has been studied for in MS, and helps you make an informed decision about whether it might be right for you.

What Is Multiple Sclerosis?

Multiple sclerosis is a chronic autoimmune disease where the immune system attacks the protective myelin sheath surrounding nerve fibers in the brain and spinal cord. This damage disrupts communication between the brain and the rest of the body, leading to a wide range of symptoms.

More than 1 million people in the United States live with MS as of 2026, according to the National Multiple Sclerosis Society. Symptoms vary widely but commonly include:

• Fatigue (affects up to 80% of MS patients)
• Numbness and tingling in the limbs
• Muscle spasticity and weakness
• Bladder and bowel dysfunction
• Vision problems
• Cognitive difficulties including brain fog
• Walking and balance problems

MS can follow different patterns. Relapsing-remitting MS is the most common form, with periods of new symptoms followed by partial or complete recovery. Progressive forms of MS involve a gradual worsening of symptoms over time.

There is currently no cure for MS. Treatment focuses on managing symptoms, slowing disease progression, and improving quality of life. This is where some patients have turned to complementary therapies like hyperbaric oxygen therapy.

How Hyperbaric Oxygen Therapy May Help MS

The theory behind using hyperbaric oxygen therapy for multiple sclerosis centers on oxygen delivery and inflammation reduction.

During a hyperbaric oxygen therapy session, you breathe pure oxygen inside a pressurized chamber at 1.5 to 2.0 times normal atmospheric pressure. This increases the amount of dissolved oxygen in your blood plasma by up to 10 to 15 times normal levels.

Researchers have proposed several mechanisms by which this increased oxygen delivery might benefit MS patients:

Reducing Inflammation

MS is fundamentally an inflammatory disease. The immune system's attack on myelin creates inflammation that damages nerve tissue. Some research suggests that hyperbaric oxygen therapy may help reduce certain inflammatory markers, potentially slowing the immune-mediated damage.

Supporting Myelin Repair

Oxygen plays a critical role in cellular repair processes. The theory is that delivering more oxygen to damaged areas of the central nervous system could support the body's natural myelin repair mechanisms. However, this remains largely theoretical in the context of MS.

Improving Blood-Brain Barrier Function

The blood-brain barrier often becomes compromised in MS, allowing immune cells to cross into the central nervous system and cause damage. Some animal studies have suggested that hyperbaric oxygen may help restore blood-brain barrier integrity, though human evidence is limited.

Reducing Fatigue Through Better Oxygenation

MS-related fatigue is one of the most debilitating symptoms and often responds poorly to medication. By increasing tissue oxygenation throughout the body, hyperbaric oxygen therapy may help address the cellular energy deficit that contributes to fatigue.

If you are exploring complementary approaches for MS, you can browse hyperbaric oxygen therapy clinics in our directory to find providers near you.

What the Research Shows

The evidence for hyperbaric oxygen therapy in multiple sclerosis is mixed. Some studies report modest benefits for specific symptoms, while others show no significant improvement compared to placebo.

The Cochrane Review

The most comprehensive analysis of HBOT for MS comes from a Cochrane systematic review by Bennett and Heard, which remains the gold standard reference as of 2026. This review analyzed nine randomized controlled trials involving 504 participants.

Key findings:

• There was no consistent evidence that hyperbaric oxygen therapy provided long-term benefit for MS patients overall
• However, there was a modest improvement in bladder function in some trials, with better outcomes for patients who received true HBOT compared to sham treatment
• The review noted that the quality of available studies was generally low, with small sample sizes and inconsistent methodologies

Early Trials and the Fischer Study

The interest in HBOT for MS surged in the 1970s and 1980s, largely driven by a study published by Fischer and colleagues in the New England Journal of Medicine in 1983. This double-blind, placebo-controlled trial of 40 patients found that:

• 12 of 17 treated patients showed improvement compared to 1 of 20 in the control group
• Improvements were primarily in mobility and bladder function
• Benefits were observed after 20 sessions at 2.0 ATA for 90 minutes each

This study generated significant excitement, but subsequent larger trials produced inconsistent results. Some replicated modest benefits for bladder symptoms, while others found no significant differences between HBOT and sham treatment.

More Recent Research

While large-scale clinical trials specifically for HBOT and MS have become less common, several smaller studies and patient surveys have contributed to our understanding:

• A survey of MS patients using HBOT therapy centers in the UK reported that many patients experienced subjective improvements in energy levels and general well-being, though these were self-reported and not controlled
• Research into HBOT's anti-inflammatory and neuroprotective effects in other neurological conditions like TBI and stroke recovery has produced more robust evidence, which some researchers believe could be relevant to MS
• Animal model studies have shown that hyperbaric oxygen can reduce demyelination and promote remyelination in experimental autoimmune encephalomyelitis, the animal model of MS

What This Means for Patients

The bottom line: the evidence for hyperbaric oxygen therapy in MS is not strong enough for it to be recommended as a standard treatment. However, some patients report meaningful symptomatic relief, particularly for fatigue and bladder symptoms. The treatment has a good safety profile when administered at appropriate pressures, which is why some patients choose to try it as a complementary therapy.

Which MS Symptoms Has HBOT Been Studied For?

Not all MS symptoms have been equally studied in the context of hyperbaric oxygen therapy. Here is what the research says about specific symptoms:

Fatigue

Fatigue is the symptom most frequently reported as improving by MS patients who use HBOT. While controlled studies have not consistently demonstrated significant improvement in fatigue scores, patient surveys from MS therapy centers consistently report that energy levels are the primary reason patients continue treatment.

Mark, a 52-year-old with relapsing-remitting MS, described his experience: "The fatigue was the worst part. After about 15 sessions, I noticed I could get through the afternoon without needing to lie down. It was not a miracle, but it was enough to make a real difference in my daily life."

Bladder Dysfunction

This is the area with the strongest evidence. The Cochrane review specifically noted modest improvements in bladder function among patients receiving HBOT. Bladder problems affect up to 80% of MS patients and can significantly impact quality of life.

Some trials measured improvements in:

• Urinary urgency
• Frequency of urination
• Bladder capacity
• Incontinence episodes

Spasticity

Results for spasticity have been inconsistent. Some early trials reported modest improvements in muscle stiffness and spasms, but later studies did not consistently replicate these findings. Patients with mild to moderate spasticity may be more likely to notice improvement than those with severe spasticity.

Vision and Cognitive Symptoms

There is limited but occasionally promising data on visual symptoms and cognitive function. Some patients report improved mental clarity and reduced brain fog after a course of HBOT sessions. However, these outcomes are difficult to measure objectively and have not been well-studied in controlled trials.

Symptom	Evidence Level	Study Findings
Fatigue	Low-moderate	Subjective improvement reported; controlled trials inconsistent
Bladder dysfunction	Moderate	Modest improvement noted in Cochrane review
Spasticity	Low	Early promise not consistently replicated
Vision problems	Very low	Anecdotal reports, minimal controlled data
Cognitive function	Very low	Self-reported improvements, needs more research
Mobility	Low	Mixed results across trials

What to Expect from HBOT Treatment for MS

If you decide to explore hyperbaric oxygen therapy for multiple sclerosis, here is what a typical treatment plan looks like.

Treatment Protocols

MS-specific HBOT protocols typically involve:

• Pressure: 1.5 to 2.0 ATA (atmospheres absolute). Most MS therapy centers use 1.5 to 1.75 ATA, which is lower than the pressures used for FDA-approved conditions like wound care
• Session duration: 60 to 90 minutes of breathing pure oxygen at pressure
• Initial course: 15 to 20 sessions, usually 5 days per week for 3 to 4 weeks
• Maintenance: Many patients continue with weekly or biweekly sessions after the initial course

During Your Session

You will lie or sit inside a pressurized chamber while breathing pure oxygen. During pressurization, you may feel pressure in your ears similar to descending in an airplane. Most people find the experience comfortable and relaxing. Some read, listen to music, or sleep during their sessions.

If this is your first time considering HBOT, our guide on what to expect at your first session covers the full experience from arrival to aftercare.

Safety Considerations

Hyperbaric oxygen therapy is generally safe when administered by trained professionals at appropriate pressures. Common side effects include:

• Ear pressure or barotrauma (the most common side effect)
• Temporary changes in vision
• Mild fatigue after sessions
• Rarely, oxygen toxicity at higher pressures

MS patients should discuss HBOT with their neurologist before starting treatment, particularly if they are taking disease-modifying therapies. There are no known drug interactions between standard MS medications and HBOT, but coordination of care is always important.

Learn more about potential side effects of hyperbaric oxygen therapy in our comprehensive guide.

Is HBOT FDA-Approved for Multiple Sclerosis?

No. Multiple sclerosis is not one of the 15 FDA-approved indications for hyperbaric oxygen therapy. This is an important distinction that affects both insurance coverage and how you should evaluate the treatment.

What This Means

• Insurance typically will not cover HBOT for MS. Because it is not FDA-approved for this condition, most health insurance plans, Medicare, and Medicaid will deny claims for HBOT used to treat MS symptoms. You will likely need to pay out of pocket.
• Typical out-of-pocket costs in 2026 range from $75 to $300 per session, depending on the clinic, chamber type, and geographic location. A full initial course of 20 sessions could cost $1,500 to $6,000. For detailed pricing information, see our hyperbaric oxygen therapy cost guide.
• Off-label does not mean ineffective. Many medical treatments are used off-label when clinical experience or preliminary research suggests potential benefit. However, the level of evidence for HBOT in MS remains lower than for many other off-label uses.

For more details on coverage, read our guide on insurance coverage for hyperbaric oxygen therapy.

The UK MS Therapy Centre Model

One interesting model comes from the United Kingdom, where over 60 MS therapy centers operated by the charity MS National Therapy Centres provide HBOT to MS patients at subsidized rates. These centers have operated since the 1980s and have treated thousands of patients.

While the centers do not claim to cure MS, they report that many patients experience improvements in fatigue, bladder function, and overall well-being. The ongoing popularity of these centers, despite limited clinical trial evidence, speaks to the subjective benefit many patients feel.

Lisa, who has been using her local MS therapy center in the UK for three years, shared: "My neurologist did not recommend it, but she did not object either. For me, the weekly sessions help with energy and sleep. I consider it part of my overall management plan alongside my medication."

Frequently Asked Questions

Does hyperbaric oxygen therapy cure multiple sclerosis?

No. There is no evidence that hyperbaric oxygen therapy can cure MS or stop the disease process. HBOT is explored as a complementary therapy that may help manage specific symptoms, particularly fatigue and bladder dysfunction. It should not replace disease-modifying therapies prescribed by your neurologist.

How many HBOT sessions do MS patients typically need?

Most protocols recommend an initial course of 15 to 20 sessions over 3 to 4 weeks. Many patients who experience benefit then continue with maintenance sessions once or twice per week. The optimal number of sessions has not been established through clinical trials, and response varies from person to person.

Can I do HBOT while taking MS medications?

Generally, yes. There are no known contraindications between standard MS disease-modifying therapies and hyperbaric oxygen therapy. However, always inform both your neurologist and the HBOT provider about all medications you are taking. Coordination between your healthcare providers is important.

What type of hyperbaric chamber is used for MS?

MS-specific HBOT is typically administered in either monoplace or multiplace chambers at pressures of 1.5 to 2.0 ATA. Some patients use mild hyperbaric chambers (1.3 ATA) at home, though these deliver lower pressures and oxygen concentrations than clinical chambers. Learn more about the differences in our soft shell vs hard shell chamber guide.

Is HBOT safe for all MS patients?

HBOT is generally safe, but certain conditions may make it unsuitable. Patients with untreated pneumothorax, certain lung conditions, or claustrophobia should discuss these with their provider. People with MS-related heat sensitivity should know that chambers are temperature-controlled and should not trigger heat-related symptom worsening.

Making Your Decision

The evidence for hyperbaric oxygen therapy in multiple sclerosis is genuinely mixed. The Cochrane review found no consistent long-term benefit, but some studies and many patient reports suggest modest improvements in fatigue and bladder function.

Here are the key takeaways:

1. HBOT is not a replacement for standard MS treatment. Disease-modifying therapies remain the cornerstone of MS management.
2. Bladder symptoms have the strongest (though still modest) evidence for improvement with HBOT.
3. Fatigue improvement is widely reported by patients but not consistently demonstrated in controlled trials.
4. The treatment is generally safe when administered at appropriate pressures by trained providers.
5. Insurance will not cover it since MS is not an FDA-approved indication. Budget $1,500 to $6,000 for an initial course.

If you decide to try HBOT as a complementary approach, the most important steps are:

• Discuss it with your neurologist
• Find a reputable clinic with experience treating neurological conditions
• Set realistic expectations based on what the evidence shows
• Track your symptoms before and during treatment to evaluate your personal response

Ready to explore your options? Browse hyperbaric oxygen therapy clinics near you or visit our multiple sclerosis condition page to find providers who treat MS patients.

Sources

1. Bennett MH, Heard R. Hyperbaric oxygen therapy for multiple sclerosis. Cochrane Database of Systematic Reviews. 2004. PubMed
2. Fischer BH, Marks M, Reich T. Hyperbaric-oxygen treatment of multiple sclerosis: a randomized, placebo-controlled, double-blind study. New England Journal of Medicine. 1983;308(4):181-186. PubMed
3. National Multiple Sclerosis Society. MS Prevalence. nationalmssociety.org
4. Defined Health Study Group. A randomized double-blind crossover trial of hyperbaric oxygen therapy in multiple sclerosis. Archives of Neurology. 1985.
5. MS National Therapy Centres. About Oxygen Therapy. msntc.org.uk

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any treatment, including hyperbaric oxygen therapy.